Lilly, J&J, AstraZeneca Dementia Drugs Boost Deaths in Study

Lilly, J&J, AstraZeneca Dementia Drugs Boost Deaths in Study
Bloomberg - Oct 18, 2005 AstraZeneca Plc’s Seroquel and Bristol- Myers Squibb Co.’s Abilify schizophrenia drugs may boost death rates in elderly patients with dementia, a new study

Related posts:

  1. Transition falls after deaths in Alzheimer’s drug study (MalaysiaNews.net)
  2. Alzheimers Disease: – Dementia sufferers’ drugs hell
  3. University Of Pennsylvania School Of Medicine And AstraZeneca Working Together To Find New Therapies For Alzheimer’s … (Medical News Today)
  4. Alzheimer’s drug trial altered after 9 deaths (AP via Yahoo! News)
  5. New Study Finds Additional Evidence that Statin Drugs May Help

Leave a Reply